What is the appropriate management for a patient with mydriasis (dilated pupils)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Mydriasis (Dilated Pupils)

The appropriate management of mydriasis (dilated pupils) requires first identifying the underlying cause through a systematic evaluation of pupillary characteristics, associated symptoms, and potential exposures, followed by targeted interventions based on the specific etiology.

Diagnostic Approach

Initial Pupil Assessment

  • Evaluate if mydriasis is unilateral or bilateral
  • Check pupillary light reactivity (direct and consensual)
  • Assess size, shape, and symmetry of pupils
  • Look for associated symptoms (pain, vision changes, headache) 1

Key Historical Elements

  • Recent medication use or exposure to:
    • Anticholinergic agents (phenothiazines, tricyclic antidepressants, antihistamines)
    • Mydriatic eye drops (tropicamide, phenylephrine)
    • Inhaled medications (ipratropium bromide) 2
    • Topical exposures (supplement powders, plant materials) 3
  • Recent trauma or surgery
  • Neurological symptoms (headache, altered consciousness)
  • Eye pain or redness 1

Etiology-Based Management

1. Pharmacological Mydriasis

Topical/Accidental Exposure

  • If suspected contamination with anticholinergic agents:
    • Irrigate the affected eye thoroughly
    • Reassure patient about temporary nature (typically resolves within 24 hours)
    • Document pupil size and monitor for resolution 3
  • For severe anticholinergic toxicity with systemic symptoms:
    • Consider physostigmine for reversal of both central and peripheral anticholinergic effects
    • Physostigmine can produce dramatic reversal within minutes if diagnosis is correct 4

Medication-Induced

  • Identify and discontinue offending agent if possible
  • For nebulized anticholinergics (e.g., ipratropium):
    • Ensure proper mask fit to prevent ocular exposure
    • Consider alternative medications if recurrent 2

2. Acute Angle-Closure Glaucoma

  • Check intraocular pressure (IOP)
  • If elevated IOP with corneal edema, pain, and mid-dilated pupil:
    • Immediate medical therapy to lower IOP (aqueous suppressants)
    • Perform laser peripheral iridotomy (LPI) once corneal edema clears 1, 5
    • Post-iridotomy management includes:
      • Topical corticosteroids to reduce inflammation
      • IOP monitoring
      • Evaluation of iridotomy patency 5
    • Prophylactic LPI in the fellow eye if anatomically narrow angle 1, 5

3. Neurological Causes

Third Nerve Palsy

  • For pupil-involving third nerve palsy:
    • Urgent neuroimaging (MRI with gadolinium and MRA or CTA) to rule out compressive lesions, especially posterior communicating artery aneurysm 1
    • If high suspicion despite normal MRA/CTA, consider catheter angiogram 1
    • Manage diplopia with:
      • Temporary occlusion (patch)
      • Botulinum toxin to opposing muscles
      • Prisms for residual diplopia 1

Stroke/Brainstem Dysfunction

  • For bilateral dilated pupils with altered consciousness:
    • Emergency neuroimaging to evaluate for basilar artery occlusion
    • Consider endovascular treatment if eligible
    • Monitor for signs of deterioration (respiratory pattern changes, motor responses) 1, 6
    • Do not assume poor prognosis based solely on bilateral mydriasis in stroke patients 6

Special Considerations

Intraoperative Unilateral Mydriasis

  • Consider topical exposure to phenylephrine or other agents used during intubation
  • Perform "wake-up" test if neurological injury is suspected
  • Monitor for changes in vital signs or other neurological indicators 7

Post-Traumatic Mydriasis

  • Urgent neuroimaging to rule out intracranial hemorrhage or mass effect
  • Ophthalmology consultation for traumatic iris damage
  • Serial pupillary examinations to monitor for changes 1

Follow-up Recommendations

  • For pharmacological mydriasis: reassess in 24-48 hours for resolution
  • For post-iridotomy patients: check IOP within 30 minutes to 2 hours post-procedure 5
  • For neurological causes: follow-up based on underlying pathology and treatment plan

Common Pitfalls to Avoid

  • Failing to distinguish between pharmacological and neurological causes
  • Overlooking inadvertent topical exposure to mydriatic agents
  • Assuming bilateral dilated pupils always indicate poor prognosis
  • Neglecting to perform compression gonioscopy in suspected angle closure
  • Delaying neuroimaging in pupil-involving third nerve palsy 1, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Post-Iridotomy Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Unilateral mydriasis after induction of anaesthesia.

Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.